Skip to content
Screener

USANA Health Sciences USNA Q1 2024 earnings

Reported April 30, 2024 · After market close

Revenue$227.8MBeat by $950.0K
EPS$0.86Beat by $0.17
Revenue estimate$226.9M
EPS estimate$0.69

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$224.7M
EPS estimate$0.43

Financials

Q1 2024

Income statement

See full
Revenue$227.8M-8.3%
Gross profit$184.7M-7.6%
Operating income$24.7M-8.1%
Net income$16.5M-10.0%
EPS (diluted)$0.86-9.5%

Balance sheet

See full
Cash & equivalents$331.1M+11.0%
Total equity$500.0M+9.8%
Total assets$629.3M+3.9%

Cash flow

See full
Operating cash flow$17.7M+37.8%
CapEx$3.2M+51.9%
Free cash flow$14.5M+35.0%

Valuation & ratios

Valuation

as of 03/30/24
See full
Market cap$796.1M-37.9%
P/E12.9×-6.8×
P/S0.9×-0.4×

Profitability

See full
Gross margin81%+0.6pp
Operating margin10.1%-0.3pp
Net margin6.9%+0.2pp
FCF margin6.7%-2.2pp

Returns & leverage

See full
Return on equity13%-2.5pp
Current ratio3.7×+0.7×

Segments

By geography

See full
Greater China$127.6M+3.1%
Americas and Europe$42.7M-12.2%
Southeast Asia Pacific$36.1M-22.1%
North Asia$21.4M-27.7%

FAQ

When did USANA Health Sciences report Q1 2024 earnings?
USANA Health Sciences (USNA) reported Q1 2024 earnings on April 30, 2024 after market close.
What were USANA Health Sciences's Q1 2024 revenue and EPS?
USANA Health Sciences reported revenue of $227.8M and eps of $0.86 for Q1 2024.
Did USANA Health Sciences beat estimates in Q1 2024?
Revenue beat the consensus estimate of $226.9M by $950.0K. EPS beat the consensus estimate of $0.69 by $0.17.
Where can I find USANA Health Sciences's Q1 2024 SEC filings?
You can read the 8-K earnings release (0000896264-24-000138) and the 10-Q periodic report (0000896264-24-000165) directly on SEC EDGAR. The filing index links above go to sec.gov.